EndoGene.Bio
Epigenetic diagnostics for early endometriosis detection.
Founded
2022
Founders
Maria Zaballos, CEO
Madeleine Moscatelli, Founding CTO
EndoGene.Bio develops a non-invasive menstrual-blood test using epigenetic biomarkers to detect endometriosis. Patients collect samples at home and get diagnostic results within two clinic visits, cutting current seven-year delays and improving access to care.
Related
2by4
2by4
Your autonomous pre-construction team.
Starting with estimates.
8x
8x
Human orchestration for business outcomes.
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA for cell modulation.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.